VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+38.18%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$186M
AUM Growth
+$186M
(+2.6%)
Cap. Flow
-$34.1M
Cap. Flow
% of AUM
-18.33%
Top 10 Holdings %
Top 10 Hldgs %
84.57%
Holding
20
New
2
Increased
2
Reduced
11
Closed
3
Top Buys
| 1 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$9.14M |
| 2 |
Heron Therapeutics
HRTX
|
$5.78M |
| 3 |
TherapeuticsMD
TXMD
|
$4.41M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$2.83M |
Top Sells
| 1 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$13.6M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$11.8M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$5.75M |
| 4 |
Neurocrine Biosciences
NBIX
|
$5.38M |
| 5 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$3.62M |
Sector Composition
| 1 | Healthcare | 60.56% |
